Lazard Asset Management LLC Abiomed Inc Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $657,875 - $817,860	2,713 Added 4.78%	59,432 $14.6 Million
Q2 2022 Aug 09, 2022	BUY	$224.73 - $338.64 $4.4 Million - $6.64 Million	19,601 Added 52.81%	56,719 $14 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $2.47 Million - $3.26 Million	8,901 Added 31.54%	37,118 $12.3 Million
Q4 2021 Feb 09, 2022	BUY	$300.63 - $371.35 $4.38 Million - $5.4 Million	14,555 Added 106.54%	28,217 $10.1 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $175,257 - $212,553	-565 Reduced 3.97%	13,662 $4.45 Million
Q2 2021 Aug 12, 2021	BUY	$262.71 - $351.17 $3.67 Million - $4.91 Million	13,971 Added 5457.42%	14,227 $4.44 Million
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $3,431 - $4,261	12 Added 4.92%	256 $81,000
Q4 2020 Feb 11, 2021	BUY	$251.88 - $324.2 $61,458 - $79,104	244 New	244 $79,000
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $137,563 - $170,863	-539 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$141.4 - $257.09 $57,974 - $105,406	-410 Reduced 43.2%	539 $130,000
Q1 2020 May 14, 2020	BUY	$130.51 - $196.01 $54,683 - $82,128	419 Added 79.06%	949 $137,000
Q4 2019 Feb 13, 2020	BUY	$159.31 - $223.54 $63,564 - $89,192	399 Added 304.58%	530 $90,000
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $23,041 - $36,579	131 New	131 $23,000
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $583,732 - $662,770	-2,326 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$276.39 - $362.25 $333,326 - $436,873	1,206 Added 107.68%	2,326 $664,000
Q4 2015 Jul 24, 2019	BUY	N/A	120 Added 12.0%	1,120 $101,000
Q3 2015 Jul 15, 2019	SELL	N/A	-600 Reduced 37.5%	1,000 $92,000
Q2 2015 Jul 08, 2019	BUY	N/A	1,600	1,600 $105,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account